IMCAS - Congresses on Dermatology and Aesthetic & Plastic Surgery

S193 Botulinum toxins - Contributed talks

vendredi 01 février 2019

08:00 to 09:00

Amphi Havane (level 3)

CONTRIBUTION

Modérateur(s)

Dr Jacques Andre DAVID

Chirurgien Cervico-Facial

France

Dr Elena RUMYANTSEVA MATHEY

Dermatologue

France

Présentations de la session

08:00

Dr Manouk MONDEEL

Advanced botulinum toxin: instructions to use

08:08

Dr Shino BAY AGUILERA

Bruxism and neurotoxins: an epidemic causing premature aging of the lower face and a multitude of medical ailments

08:16

Keith FOSTER

Botulinum neurotoxin content and activity: Implications for duration of efficacy

08:24

Dr Laurent PONS

Outcomes of the first-in-human study with a recombinant botulinum toxin E (rBoNT-E): safety and pharmacodynamic profile of rBoNT-E compared with abobotulinumtoxinA

08:32

Prof Elena GUBANOVA

Dosing of abobotulinumtoxinA for long-term treatment of glabellar lines: injection practices from the APPEAL non-interventional study

08:40

Dr Beatriz MOLINA

High subject satisfaction after aesthetic treatment of glabellar lines with abobotulinumtoxinA in up to three injection cycles

08:48

Prof Martina J KERSCHER

Safety, tolerability, and efficacy of repeat-dose injections of incobotulinum toxin / type A in the treatment of upper facial lines

Sessions à ne pas manquer

Male combined treatments S098

MENA - Complications or side effects with injectables: how to deal with them? (in collaboration with SHARM DERMA) S263

Symposium de l'industrie

Luminera Derm Symposium - The full line of injectable beauty solutions S278

Symposium de l'industrie

Fidia Farmaceutici Symposium - The innovative approach with autologous tissue therapy: a journey from HA - ACP technology to SVF S323

Symposium de l'industrie

IBSA Farmaceutici Italia Symposium - Hybrid cooperative complex HA (Profhilo®): integrative, evidence based solution for multi-level tissue remodeling S215

Vous avez une question ?

Attention

Modérateur(s)

Présentations de la session

Sessions à ne pas manquer

Vous avez une question ?

Erreur